本页面由Tiger Trade Technology Pte. Ltd.提供服务

BridgeBio Pharma, Inc.

73.91
+1.211.66%
成交量:57.25万
成交额:4,195.45万
市值:142.42亿
市盈率:-17.66
高:74.27
开:74.02
低:72.42
收:72.70
52周最高:75.10
52周最低:25.34
股本:1.93亿
流通股本:1.51亿
量比:0.62
换手率:0.38%
股息:- -
股息率:- -
每股收益(TTM):-4.1844
每股收益(LYR):-2.8793
净资产收益率:-1789.67%
总资产收益率:-43.47%
市净率:-7.37
市盈率(LYR):-25.67

数据加载中...

2025/08/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/05

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/08/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/05

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/08/05

重要事件披露

Form 8-K - Current report
2025/07/02

重要事件披露

Form 8-K - Current report
2025/07/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/07/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/06/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/06/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/06/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/06/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/06/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/06/23

重要事件披露

Form 8-K - Current report
2025/06/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/05/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/05/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/05/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/04/30

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/04/29

重要事件披露

Form 8-K - Current report